These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial. Lesage E; Aronson SE; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA JAMA Psychiatry; 2017 Jun; 74(6):632-640. PubMed ID: 28403383 [TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking and nicotine addiction. Benowitz NL Med Clin North Am; 1992 Mar; 76(2):415-37. PubMed ID: 1548969 [TBL] [Abstract][Full Text] [Related]
6. Neurobehavioral mechanisms of nicotine action: role in the initiation and maintenance of tobacco dependence. Rosecrans JA; Karan LD J Subst Abuse Treat; 1993; 10(2):161-70. PubMed ID: 8510190 [TBL] [Abstract][Full Text] [Related]
7. The smoking gun: many conditions associated with tobacco exposure may be attributable to paradoxical compensatory autonomic responses to nicotine. Yun AJ; Bazar KA; Lee PY; Gerber A; Daniel SM Med Hypotheses; 2005; 64(6):1073-9. PubMed ID: 15823687 [TBL] [Abstract][Full Text] [Related]
8. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Benowitz NL Am J Med; 2008 Apr; 121(4 Suppl 1):S3-10. PubMed ID: 18342164 [TBL] [Abstract][Full Text] [Related]
9. Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications. D'Souza MS Prog Brain Res; 2016; 223():191-214. PubMed ID: 26806777 [TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate receptor 5 as a potential target for smoking cessation. Chiamulera C; Marzo CM; Balfour DJK Psychopharmacology (Berl); 2017 May; 234(9-10):1357-1370. PubMed ID: 27847973 [TBL] [Abstract][Full Text] [Related]
11. Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine. Ochoa EL; Li L; McNamee MG Mol Neurobiol; 1990; 4(3-4):251-87. PubMed ID: 2135395 [TBL] [Abstract][Full Text] [Related]
13. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. D'Souza MS; Markou A Addict Sci Clin Pract; 2011 Jul; 6(1):4-16. PubMed ID: 22003417 [TBL] [Abstract][Full Text] [Related]
14. New mechanisms and perspectives in nicotine withdrawal. Jackson KJ; Muldoon PP; De Biasi M; Damaj MI Neuropharmacology; 2015 Sep; 96(Pt B):223-34. PubMed ID: 25433149 [TBL] [Abstract][Full Text] [Related]
15. Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review. Menossi HS; Goudriaan AE; de Azevedo-Marques Périco C; Nicastri S; de Andrade AG; D'Elia G; Li CS; Castaldelli-Maia JM CNS Drugs; 2013 Nov; 27(11):921-41. PubMed ID: 23853032 [TBL] [Abstract][Full Text] [Related]
16. Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence. Balfour DJ Curr Drug Targets CNS Neurol Disord; 2002 Aug; 1(4):413-21. PubMed ID: 12769613 [TBL] [Abstract][Full Text] [Related]
17. The neuronal pathways mediating the behavioral and addictive properties of nicotine. Balfour DJ Handb Exp Pharmacol; 2009; (192):209-33. PubMed ID: 19184651 [TBL] [Abstract][Full Text] [Related]
18. The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Balfour DJ; Wright AE; Benwell ME; Birrell CE Behav Brain Res; 2000 Aug; 113(1-2):73-83. PubMed ID: 10942034 [TBL] [Abstract][Full Text] [Related]